Literature DB >> 8974074

Characterization of anti-heart M2 muscarinic receptor antibodies--a combined clinical and experimental study.

M L Fu1.   

Abstract

To elucidate the relationship between autoimmunity and idiopathic dilated cardiomyopathy has been one of today's heated topics in the field of heart research. So far it has been identified that there are a variety of autoantibodies including antireceptor autoantibodies. However, the role of these autoantibodies in the development of dilated cardiomyopathy has not been defined. An increasing number of in vitro studies showed that these autoantibodies had different functions, suggesting that they may play different roles in the pathogenesis of cardiomyopathy. The main purpose of this article is to briefly go through the results obtained from both clinical and experimental in vitro studies on anti-M2 muscarinic receptor antibodies to see where we stand in the understanding of the role of these autoantibodies in the pathogenesis of idiopathic dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8974074     DOI: 10.1007/bf00408675

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  Functional epitope analysis of the second extracellular loop of the human heart muscarinic acetylcholine receptor.

Authors:  M L Fu; W Schulze; G Wallukat; A Hjalmarson; J Hoebeke
Journal:  J Mol Cell Cardiol       Date:  1995-01       Impact factor: 5.000

2.  Immunocytochemical studies of M2 muscarinic receptors in guinea pig atria and ventricles using anti-peptide antibodies.

Authors:  L Zhu; W Z Wang; X H Jin; R R Zhao; A Hjalmarson; M L Fu
Journal:  Blood Press Suppl       Date:  1996

3.  Muscarinic receptor regulation of cardiac adenylate cyclase activity.

Authors:  J W Fleming; R A Strawbridge; A M Watanabe
Journal:  J Mol Cell Cardiol       Date:  1987-01       Impact factor: 5.000

4.  Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.

Authors:  C J Limas; I F Goldenberg; C Limas
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

5.  Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function.

Authors:  K Schulze; B F Becker; R Schauer; H P Schultheiss
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

6.  Effects of anti-peptide antibodies against human M2 muscarinic receptors on the cAMP generating system in guinea pig ventricles.

Authors:  W Z Wang; R R Zhao; L Zhu; X H Jin; A Hjalmarson; M L Fu
Journal:  Blood Press Suppl       Date:  1996

7.  Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

Authors:  L X Fu; Y Magnusson; C H Bergh; J A Liljeqvist; F Waagstein; A Hjalmarson; J Hoebeke
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Chagasic IgG binding with cardiac muscarinic cholinergic receptors modifies cholinergic-mediated cellular transmembrane signals.

Authors:  L Sterin-Borda; G Gorelik; E S Borda
Journal:  Clin Immunol Immunopathol       Date:  1991-12

9.  HLA-DR antigen linkage of anti-beta receptor antibodies in idiopathic dilated and ischaemic cardiomyopathy.

Authors:  C J Limas; C Limas
Journal:  Br Heart J       Date:  1992-05

10.  Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension.

Authors:  M L Fu; J Hoebeke; S Matsui; M Matoba; Y Magnusson; T Hedner; H Herlitz; A Hjalmarson
Journal:  Clin Immunol Immunopathol       Date:  1994-07
View more
  1 in total

Review 1.  Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.

Authors:  Alida L P Caforio; Renzo Marcolongo; Roland Jahns; Michael Fu; Stephan B Felix; S Iliceto
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.654

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.